Form 4 for BDX Becton Dickinson
Accepted 2024-08-21 00:00:00 ET · period of report 2024-08-20 · accession 0001062993-24-015500 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-21 | 2024-08-20 | BDX | Feld Michael | EVP, Pres, Life Sciences | A - Grant | $0.00 | +6,637 | 6,637 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-20 | A | A | 6,637 | $0.00 | 6,637 | D | — | — | (F1) Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |